Matthew Liakos1, Puja B Parikh2,3. 1. Division of Cardiovascular Medicine, Department of Medicine, State University of New York, Stony Brook, NY, USA. 2. Division of Cardiovascular Medicine, Department of Medicine, State University of New York, Stony Brook, NY, USA. puja.parikh@stonybrookmedicine.edu. 3. Health Sciences Center T16-080, Stony Brook University Medical Center, Stony Brook, NY, 11794, USA. puja.parikh@stonybrookmedicine.edu.
Abstract
PURPOSE OF REVIEW: This review provides updates in gender disparities in the symptom profile, risk factors, quality and timeliness of guideline-based medical care, and clinical outcomes, including mortality, bleeding, and vascular complications, in patients with acute myocardial infarction (AMI). RECENT FINDINGS: While AMI continues to be a leading cause of mortality in both men and women, significant gender differences exist in presentation, management, and outcomes. Women with AMI are older, suffer atypical symptoms, and more often present with HF and cardiogenic shock. Delays in medical care and hence longer ischemic times exist in women, partly due to decreased awareness and lack of symptom recognition. Women continue to be less likely to receive guideline-based pharmacological therapies and revascularization than men with AMI. While women suffer from significantly higher risk-adjusted rates of bleeding, vascular complications, and short-term mortality, the risk-adjusted rates of long-term mortality remain similar between men and women. Further investigations and efforts are needed to aggressively modify risk factors, reduce delays in care, and address the higher rates of adverse events seen in women with AMI. Significant sex disparities are prevalent in presentation, management, and outcomes of adults with AMI. Further investigations and efforts are needed to aggressively modify risk factors, reduce delays in care, and address the higher rates of adverse events seen in women with AMI.
PURPOSE OF REVIEW: This review provides updates in gender disparities in the symptom profile, risk factors, quality and timeliness of guideline-based medical care, and clinical outcomes, including mortality, bleeding, and vascular complications, in patients with acute myocardial infarction (AMI). RECENT FINDINGS: While AMI continues to be a leading cause of mortality in both men and women, significant gender differences exist in presentation, management, and outcomes. Women with AMI are older, suffer atypical symptoms, and more often present with HF and cardiogenic shock. Delays in medical care and hence longer ischemic times exist in women, partly due to decreased awareness and lack of symptom recognition. Women continue to be less likely to receive guideline-based pharmacological therapies and revascularization than men with AMI. While women suffer from significantly higher risk-adjusted rates of bleeding, vascular complications, and short-term mortality, the risk-adjusted rates of long-term mortality remain similar between men and women. Further investigations and efforts are needed to aggressively modify risk factors, reduce delays in care, and address the higher rates of adverse events seen in women with AMI. Significant sex disparities are prevalent in presentation, management, and outcomes of adults with AMI. Further investigations and efforts are needed to aggressively modify risk factors, reduce delays in care, and address the higher rates of adverse events seen in women with AMI.
Authors: W Brian Gibler; Paul W Armstrong; E Magnus Ohman; W Douglas Weaver; Amanda L Stebbins; Joel M Gore; L Kristin Newby; Robert M Califf; Eric J Topol Journal: Ann Emerg Med Date: 2002-02 Impact factor: 5.721
Authors: Jacqueline Saw; Karin Humphries; Eve Aymong; Tara Sedlak; Roshan Prakash; Andrew Starovoytov; G B John Mancini Journal: J Am Coll Cardiol Date: 2017-08-29 Impact factor: 24.094
Authors: Andra L Blomkalns; Anita Y Chen; Judith S Hochman; Eric D Peterson; Kelly Trynosky; Deborah B Diercks; Gerard X Brogan; William E Boden; Matthew T Roe; E Magnus Ohman; W Brian Gibler; L Kristin Newby Journal: J Am Coll Cardiol Date: 2005-03-15 Impact factor: 24.094
Authors: Jeffrey S Berger; Laine Elliott; Dianne Gallup; Matthew Roe; Christopher B Granger; Paul W Armstrong; R John Simes; Harvey D White; Frans Van de Werf; Eric J Topol; Judith S Hochman; L Kristin Newby; Robert A Harrington; Robert M Califf; Richard C Becker; Pamela S Douglas Journal: JAMA Date: 2009-08-26 Impact factor: 56.272
Authors: Manal Alasnag; Alexander G Truesdell; Holli Williams; Sara C Martinez; Syeda Kashfi Qadri; John P Skendelas; William A Jakobleff; Mirvat Alasnag Journal: Curr Atheroscler Rep Date: 2020-04-23 Impact factor: 5.113
Authors: Saraschandra Vallabhajosyula; Saarwaani Vallabhajosyula; Shannon M Dunlay; Sharonne N Hayes; Patricia J M Best; Jorge A Brenes-Salazar; Amir Lerman; Bernard J Gersh; Allan S Jaffe; Malcolm R Bell; David R Holmes; Gregory W Barsness Journal: Mayo Clin Proc Date: 2020-09 Impact factor: 7.616
Authors: Fiorella Pia Salvatore; Alessia Spada; Francesca Fortunato; Demetris Vrontis; Mariantonietta Fiore Journal: Int J Environ Res Public Health Date: 2021-04-27 Impact factor: 3.390
Authors: Victor Okunrintemi; Javier Valero-Elizondo; Benjamin Patrick; Joseph Salami; Martin Tibuakuu; Saba Ahmad; Oluseye Ogunmoroti; Shiwani Mahajan; Safi U Khan; Martha Gulati; Khurram Nasir; Erin D Michos Journal: J Am Heart Assoc Date: 2018-12-18 Impact factor: 5.501